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Abstract
Background: The aim of this project was to assess whether outreach visits would improve the
implementation of evidence based clinical practice in the area of falls reduction and stroke prevention in
a residential care setting.
Methods: Twenty facilities took part in a randomized controlled trial with a seven month follow-up
period. Two outreach visits were delivered by a pharmacist. At the first a summary of the relevant
evidence was provided and at the second detailed audit information was provided about fall rates,
psychotropic drug prescribing and stroke risk reduction practices (BP monitoring, aspirin and warfarin
use) for the facility relevant to the physician. The effect of the interventions was determined via pre- and
post-intervention case note audit. Outcomes included change in percentage patients at risk of falling who
fell in a three month period prior to follow-up and changes in use of psychotropic medications. Chi-square
tests, independent samples t-test, and logistic regression were used in the analysis.
Results: Data were available from case notes at baseline (n = 897) and seven months follow-up (n = 902),
452 residential care staff were surveyed and 121 physicians were involved with 61 receiving outreach visits.
Pre-and post-intervention data were available for 715 participants. There were no differences between the
intervention and control groups for the three month fall rate. We were unable to detect statistically
significant differences between groups for the psychotropic drug use of the patients before or after the
intervention. The exception was significantly greater use of "as required" antipsychotics in the intervention
group compared with the control group after the pharmacy intervention (RR = 4.95; 95%CI 1.69–14.50).
There was no statistically significant difference between groups for the numbers of patients "at risk of
stroke" on aspirin at follow-up.
Conclusions: While the strategy was well received by the physicians involved, there was no change in
prescribing patterns. Patient care in residential settings is complex and involves contributions from the
patient's physician, family and residential care staff. The project highlights challenges of delivering evidence
based care in a setting in which there is a paucity of well controlled trial evidence but where significant
health outcomes can be attained.
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While some of the frailest members of our community
live in residential care, their medical care is widely
believed to be suboptimal. It is unclear to what extent the
problems with treating this group is the result of lack of
knowledge, discomfort about the risk/benefit profile of
treatments in the very old or structural issues within resi-
dential care which inhibit clinical effectiveness. There is
some evidence that improvements in prescribing can be
achieved using outreach visits and educational strategies
such as "academic detailing" with providers in residential
care [1]. However there has been no examination of this
approach when applied to the implementation of clinical
guidelines within residential care.
Two key health areas for older adults in residential care are
falls and stroke prevention. Falls and consequent injuries
are a major public health problem in nursing home resi-
dents and herald a functional decline and loss of inde-
pendence [2,3]. Achieving reductions in falls in residential
care settings has proved difficult. While a trial in two nurs-
ing homes [4] and a trial using geriatric assessment [5]
failed to reduce fall rates, a multidisciplinary consultative
program targeting the 25% of nursing home patients at
highest risk for falls was able to demonstrate a reduction
in the number of falls [6]. The key elements of this pro-
gram were an interdisciplinary approach with the
appointment of a falls coordinator at each facility with
responsibility for the implementation of the program.
Stroke is a leading cause of disability for elderly Austral-
ians [7]. While there is robust evidence that secondary pre-
vention (identification and treatment of high risk groups)
can improve outcomes with significant reductions in mor-
bidity and death [8,9], there is also evidence that primary
care physicians are failing to apply this evidence in resi-
dential care settings. For example, only 40% of patients in
one survey of secondary stroke prevention in nursing
homes were shown to be adequately anticoagulated [10].
While outreach visit programs have been effective
approaches to implementing evidence based practice in
other primary care settings [11] they are yet to be evalu-
ated in residential care. Therefore, the aim of the SAFIRE
(Strokes And Falls In Residential care Evaluation) project
was to examine the impact of an outreach visit interven-
tion, targeting falls reduction and stroke prevention in a
residential care setting. Our hypothesis was that prescrib-
ing patterns and risk factor modification would occur
more frequently in those facilities who had received the
outreach intervention than in those who had not.
Methods
The SAFIRE project was a randomised controlled trial
involving a multifaceted intervention conducted in resi-
dential care facilities in metropolitan Adelaide, South
Australia. Ethics approval was granted by the Research and
Ethics Committee, Repatriation General Hospital,
Adelaide.
Facilities were chosen across the metropolitan health
areas of Adelaide, South Australia. Each region was ran-
domly allocated as intervention or control. The first facil-
ity to be included in the study was selected at random and
matched to a facility in another region to avoid overlap of
physicians. The remaining facilities were selected in the
same manner until the cumulative number of residents
met the estimated sample size required (n = 20 facilities,
10 hostels – low level care and 10 nursing homes – high
level care). The sample size was calculated assuming a
10% reduction in falls rate in the intervention group and
estimated to be 348. All randomisation was conducted
using a computer-generated random allocation program
by a person external to the project. Figure 1 presents a vis-
ual description of the study design. Informed consent was
obtained from the resident or their next of kin in order to
access case notes. A list of all primary care physicians
attending each facility and the number of patients they
treated was drawn up. Commencing with those physi-
cians with the largest number of patients they were
approached to take part in the study. Six physicians per
facility (120 in total) were recruited for the study and all
were only treating patients in either the intervention
region or the control region.
All patients/carer of the participating residential care facil-
ities were approached for consent to allow an audit of the
clinical practice in each facility. Case notes were audited
by nurses blinded to allocation for demographic informa-
tion, diagnoses and stroke risk factors. Medication charts
were reviewed for prescription and administration of any
psychotropic and/or antihypertensive medication and use
of aspirin or warfarin. Information was also collected on
the number of falls and injurious falls in the last 12
months from incident report forms at each facility. Seven
months after baseline measures were taken, the case note
audit was repeated for all consenting residents.
Intervention physicians received two, 30 min detailing
visits by a pharmacist in their surgeries. The key messages
combined the evidence based guidelines on falls preven-
tion [12,13] with information from the case note audit
and survey and included: the benefits of the use of aspirin
in residents with increased stroke risk, the monitoring and
treatment of hypertension, the benefits of the use of war-
farin in residents with atrial fibrillation, and the risk of
psychotropic drug use. There is little evidence specific to
patients in residential care settings for the management of
stroke risk factors. We adhered to guidelines for commu-
nity based patients eg WHO guidelines for hypertensionPage 2 of 6
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were also provided with detailed audit information on the
facility where the physician worked including falls rates,
psychotropic prescribing patterns, stroke risk reduction
practices (BP monitoring, aspirin and warfarin use). The
use of pharmacists to provide this information has been
used in previous studies in this region and was familiar
and acceptable to the physicians.
One nurse per facility was appointed as a link nurse. The
link nurses underwent four two-hour sessions in change
management, management of the behavioural symptoms
of dementia, medication management and falls preven-
tion techniques. In addition, a pharmacist visited each
facility and spoke to staff on reducing the use of psycho-
tropic medications.
The primary outcome for the project was the three month
fall rate prior to the follow-up assessment. Secondary out-
comes included 12 month fall rate, rate of injurous falls,
recorded blood pressure readings from previous three
months, prescription and administration of any psycho-
tropic medication, prescription of aspirin or warfarin, or
an antihypertensive, Modified Barthel Index – Activity of
Daily Living (ADL) score [15], Nursing Home Life-Space
Diameter – Mobility score [16] and The Nursing Home
Problem Behaviour Scale [17].
To assess the reliability of the case note data extraction
and reduce inter-observer error, five percent of records
from the first audit had data extracted twice and 10% of
records were extracted twice from the second. Reliability
(measured by Pearson's correlation coefficient for contin-
uous variables and % agreement for categorical variables)
was 95% or greater on demographic and drug usage data.
Descriptive data are reported as percentages and means
and standard deviation. Chi-squared tests were used for
assessing differences in proportions between study
groups, whereas Student's t tests were used to compare
means. Relative risks for the effect of the intervention after
adjusting for age, gender, level of care, dementia status,
and baseline levels of the outcome measure were under-
taken using generalized linear models. To account prop-
erly for the cluster randomisation design used, the facility
was recognised as the primary sampling unit in all analy-
ses. All statistical analyses were undertaken using the
STATA statistical package [18].
Results
Twenty facilities were involved in the trial; 10 hostels (low
level facilities) and 10 nursing homes (high level facili-
ties). The total number of potential participants for the
first case note audit was 1061 and of these, 897 (85%)
consented to participate. Next of kin consent was
obtained in 50.4% (range 26–80% for facilities) of cases.
At the second audit 1055 potential participants were avail-
able, 902 (85%) consented to involvement with 46.7%
requiring next of kin consent. Two hundred and two peo-
ple (22.5%) who participated at the first audit were not
available at the second due to various reasons including
death and moving facility. The attrition rate was as high as
37% in some facilities but there were no overall differ-
ences in attrition rate between the intervention and con-
trol facilities (p = 0.086). Those participants that were
missing at the second audit were more likely to be male (p
=< 0.001) and be older (p = 0.003) than participants avail-
able for follow-up at the second audit. There was no dif-
ference in the number of those diagnosed with dementia
(p = 0.884), having antipsychotics or benzodiazepines
administered regularly (p = 0.40 and p = 0.346 respec-
tively), or having fallen in the previous three months (p =
0.768). Of the 121 primary care physicians approached to
participate, 98 (81%) consented with 61 attending inter-
vention and 37 attending control facilities, respectively.
GPs in the control region had larger numbers of patients
under their care. These physicians cared for 59% of the
residential care residents whose notes were audited.
Table 1 describes the baseline characteristics of the resi-
dents. At baseline, residents from the intervention group
were more likely to have resided at the facility for less than
three months (p = 0.04), were more likely to have a diag-
nosis of dementia (p = 0.01) and were more likely to have
documentation of not for resuscitation (p < 0.001). There
were no differences between groups for a diagnosis of
depression, length of stay at facility or mean number of
recent unplanned hospital visits. Residents in the inter-
vention group facilities were more likely to be prescribed
a psychotropic medication or benzodiazepine on an "as
required" (PRN) basis than those in the control facilities
(p < 0.05). Seventy-one percent were at risk of falls or
stroke, 48% had fallen in the last 12 months and 23% of
residents had had a stroke in the past. Sixty-seven percent
were prescribed a psychotropic medication, with a higher
rate in nursing homes compared with hostels (74% v
62%). Overall 35% of residents were on aspirin. However,
of those identified at high risk of stroke (prior stroke/TIA
or with a known risk factor) only 45% were treated with
aspirin. Less than half of the residents identified at risk of
stroke (35% in nursing homes and 43% in hostels) had a
blood pressure measurement recorded in the prior three
months.
Over the period of the intervention, the percentage of res-
idents who reported one or more falls in the previous
three months increased for both the intervention and con-
trol groups, however, there were no differences in the fall
rate between groups (Table 2).Page 3 of 6
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detect statistically significant differences between the
groups for the psychotropic drug use of the patients before
or after the intervention. The exception was significantly
greater use of "as required" antipsychotics in the interven-
tion group compared with the control group after the
pharmacy intervention (RR = 4.95; 95%CI 1.69–14.50)
(Table 2).
There were no differences between groups for the record-
ing of blood pressure or the percentages of patients with a
recorded blood pressure of greater than 140/90 mm Hg.
The percentage of residents on aspirin, percentage of resi-
dents with atrial fibrillation and use of warfarin was simi-
lar between groups (Table 3).
Discussion
A systematic review of interventions designed to change
physician's performance reported that outreach visits were
an effective strategy [19]. Furthermore, the more educa-
tional methods are used the greater the chance of chang-
ing practice [19]. This randomised controlled trial used
outreach visits incorporating audit, feedback and educa-
tion. Despite the previous success of this approach in a
residential care setting [1], we were unable to detect a
Table 1: Characteristics of residents at baseline (n = 715).
Characteristics of residents at baseline Control (n = 334) Intervention (n = 381)
Age (yr)* 83.4 ± 7.9 84.7 ± 7.7
Gender – Male (%) 18.0 14.5
Female (%) 82.0 85.5
Diagnosis of dementia in case notes n (%) 103 (33.4) 162 (42.7)
Diagnosis of depression in case notes n (%) 64 (19.2) 67 (17.8)
Length of Stay in residential care facility (days) 40.1 ± 39.5 35.7 ± 39.5
Length of Stay – less than 3 months (%) 5.4 9.4
Length of Stay – less than 12 months (%) 24.4 29.7
Documented "not for resuscitation" in case notes (%) 1.9 10.3
Mean number of unplanned hospital visits in prior 3 months* 0.08 ± 0.38 0.05 ± 0.25
*Mean ± SD
Table 2: Fall rates and use of psychotropic drugs in control and intervention facilities, before and after implementation of the 
intervention.
Control (n = 334) Intervention (n = 381) Statistics
Before After Before After RR* 95% CI
Falls
Residents who fell in 3 months prior (%) 19.8 21.9 22.0 25.5 1.17 0.86 – 1.58
Any psychotropics (%)
Residents Prescribed 63.8 68.1 70.0 69.9 0.89 0.69 – 1.15
Administered Regularly 45.2 48.8 40.2 40.4 0.93 0.82 – 1.05
Marked PRN (& not Reg.) 12.2 8.8 23.1 16.3 1.48 0.79 – 2.77
Benzodiazepines (%)
Residents Prescribed Any Benzodiazepines 43.7 43.7 45.4 39.1 0.89 0.69 – 1.15
Residents Prescribed Long Acting Benzodiazepines 13.8 12.9 10.9 8.1 0.76 0.56 – 1.03
Residents Prescribed Short Acting Benzodiazepines 35.3 34.1 37.7 32.3 0.95 0.70 – 1.28
Any Administered Regularly 32.0 32.0 28.1 24.7 0.87 0.69 – 1.09
Any Marked PRN (& not Reg.) 8.8 7.8 17.2 13.0 1.31 0.62 – 2.73
Antipsychotics (%)
Residents Prescribed 24.6 23.1 23.6 24.9 0.96 0.69 – 1.34
Administered Regularly 18.6 22.5 17.6 20.5 1.01 0.87 – 1.18
Marked PRN (& not Reg.) 4.5 0.9 6.6 4.5 4.95 1.69 – 14.50
* Comparison of Intervention and Control groups post intervention after adjusting for pre-intervention results and statistically significant covariates. 
Notes: Percentages were calculated from residents present during both audits. The category "psychotropics" include residents prescribed any of 
benzodiazepines, antipyschotics or antidepressants. Marked PRN (& not Reg.) refers to medications administered as the occasion arose but not 
regularly administered.Page 4 of 6
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stroke in the participating residential care facilities.
Some aspects of the trial design may have reduced the
likelihood of an effect. The timeframe of the trial limited
the level of involvement of the facilities and impacted on
the sustainability of any changes. The rate of reporting of
falls increased in both groups probably reflecting an
increase in the awareness and documentation of falls and
the rate of attrition of residents over the period of follow-
up was higher than expected with 23% of residents mov-
ing or dying during the period of the trial. There were also
difficulties with delivering the message in the residential
care setting with a high turnover of staff. The attrition rate
of staff was 13% in a six month period and a number of
physicians attending the facilities had only one or two
patients. Participating physicians cared for 59% of the res-
idential care residents whose notes were audited and the
omission of the other GPs may have diluted the overall
effect. Many of these limitations may have impacted on
the results found however we did conduct a satisfaction
survey with residential care staff and focus groups with the
facility staff and physicians which indicated that the
detailing visits were important in increasing awareness,
this is the subject of a separate manuscript. Both interven-
tion and control facilities were audited at the beginning
and end of the study and this scrutiny may have impacted
on reporting and recording practices in both groups affect-
ing the recording of outcomes eg falls.
This project highlighted many barriers to the successful
implementation of evidence based clinical practice in res-
idential care. Collection of data via case note audit
required patient consent and for around 50% of residents
this involved next of kin consent. Developing evidence
based guidelines for managing patients in residential care
was limited by the few trials including adults over 80 years
of age. Furthermore, there were complexities in the devel-
opment of best clinical management. An example of this
was the recommended use of aspirin or warfarin to reduce
stroke risk versus the potential for bleeding
complications.
Structural issues in residential care may impact on the way
that care is delivered. The decision to use many medica-
tions, particularly psychotropic medications, is influenced
by a variety of people including the patient, residential
care staff and the patient's next of kin as well as the physi-
cian. Carers, rather than nurses, are responsible for most
of the day-to-day monitoring of residents behaviours and
interventions focusing on professionals such as doctors
and nurses may not be sufficient in this setting. In Aus-
tralia current funding arrangements for residential care
include few incentives for either physicians or residential
care administration staff to improve clinical care and
accreditation processes largely focus on accommodation
issues rather than health care. General practitioners are
under-supported due to an absence of medical advisory
boards, a lack of audit, review and monitoring systems
and communication difficulties between physicians, nurs-
ing staff and carers.
We were pleased, however, to find substantial interest in
this trial from both the facilities and the physicians who
visit them. This has resulted in commitment to a further
project examining methods for enhancing communica-
tion within residential care facilities via case conferencing.
This trial also resulted in the establishment of links
between the hospital and residential care with future edu-
cational courses underway.
Table 3: Blood pressure recording, patients at risk of stroke and use of aspirin and warfarin in control and intervention facilities, before 
and after implementation of the intervention.
Control Intervention Statistics
Before After Before After RR* P value 95% CI
BP Recorded in prior 3 months 36.5 46.4 31.9 46.8 0.94 0.491 0.80 – 1.11
BP recorded and Systolic BP > 140 mm Hg‡ 50.0 47.7 43.4 46.7 1.01 0.955 0.69 – 1.47
BP recorded and Diastolic BP > 90 mm Hg‡ 5.7 4.5 4.4 0 #
At Risk of Stroke 59.0 65.0 54.9 57.7 0.65 0.096 0.39 – 1.08
On Aspirin 38.9 41.0 33.4 35.4 0.98 0.608 0.89 – 1.06
Residents at risk of stroke and on Aspirin§ 50.3 52.5 41.6 44.1 0.54 0.048 0.29 – 1.00
Residents with Atrial Fibrillation recorded 9.3 10.5 9.4 9.4 0.90 0.688 0.54 – 1.49
% of Residents with Atrial Fibrillation 
recorded on Warfarin||
22.6 17.1 8.6 16.7 0.92 0.900 0.23 – 3.59
Analyses were adjusted for age, gender, level of care, dementia and baseline values. * Comparison of Intervention and Control groups post 
intervention after adjusting for pre-intervention results and statistically significant covariates. † Relative risk unable to be calculated due to 
insufficient numbers ‡: Control (n = 122) and Intervention (n = 113) § Control (n = 193) and Intervention (n = 212) ||: Control (n = 31) and 
Intervention (n = 36)Page 5 of 6
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This project found that while an outreach visit strategy
was well received by physicians and facility staff involved
it did not result in changes to the clinical management of
residents. It highlighted the challenges of delivering evi-
dence based care in a setting in which there is a paucity of
well controlled trial evidence but where significant health
outcomes can be attained. Residential care is a unique pri-
mary care setting. Interventions designed to change
patient care require the inclusion of their usual physician
and other individuals involved with the patient such as
the residential care staff and next of kin. Furthermore,
implementing evidence based practice in residential care
setting represents a substantial challenge due to the lack of
good quality evidence.
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